Preferential distribution of lobar emphysema and atelectasis in bronchopulmonary dysplasia

Pediatrics
|January 1, 1979
PubMed

Insights

Bronchopulmonary dysplasia (BPD) in neonates can cause right lower lobe hyperinflation and right upper lobe collapse. This condition, often linked to emphysema, typically resolves with supportive care.

Area of Science:

  • Neonatal Medicine
  • Pediatric Pulmonology
  • Radiology

Background:

  • Mechanical ventilation is crucial for neonates with respiratory distress syndrome and prolonged apnea.
  • Bronchopulmonary dysplasia (BPD) is a significant complication in infants requiring prolonged ventilation.
  • Specific radiographic patterns, including lobar hyperinflation and atelectasis, are observed in BPD.

Purpose of the Study:

  • To investigate the characteristics and implications of lobar hyperinflation and atelectasis in neonates with BPD.
  • To differentiate the causes of hyperinflation in BPD, distinguishing it from compensatory mechanisms.
  • To evaluate the temporal course and potential complications of these lung abnormalities.

Main Methods:

  • Retrospective review of chest roentgenograms from 142 neonates who underwent mechanical ventilation.
  • Identification of infants with bronchopulmonary dysplasia (BPD) and specific lobar abnormalities.
  • Regional lung function assessment using xenon 133 in a subset of patients.

Main Results:

  • 17 out of 37 infants with BPD exhibited right lower lobe hyperinflation and right upper lobe collapse.
  • Xenon 133 studies indicated reduced ventilation in the lower lung regions, suggesting emphysema rather than compensatory hyperinflation.
  • Regional perfusion was uniform, and the lobar emphysema with ipsilateral atelectasis typically resolved within eight weeks, with minimal association with pneumonia.

Conclusions:

  • Right lower lobe hyperinflation and right upper lobe collapse in BPD are associated with emphysema.
  • These radiographic findings in BPD have a characteristic presentation and resolution pattern.
  • Supportive care is the recommended management approach for these BPD-related lung abnormalities.

Related Concept Videos

Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Atelectasis II: Pathophysiology01:10

Atelectasis II: Pathophysiology

Atelectasis develops when alveoli lose their air and collapse inward. Because lung tissue is naturally elastic, these air sacs shrink rather than remaining open. Collapsed alveoli are no longer ventilated, reducing their role in gas exchange. Blood flow may continue in these regions, creating a ventilation–perfusion mismatch. Clinical findings include decreased breath sounds, dullness to percussion, reduced chest expansion, and decreased tactile fremitus as sound transmission through collapsed...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...